Triple-negative breast cancer (TNBC) accounts for about 15% -20% of all breast cancers and is the deadliest breast cancer subtype characterized by a lack of oestrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER-2) expression (1, 2). Here, ERBB2 is linked to triple-negative breast carcinoma.